 | • レポートコード：MR2211MG03131 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：化学&材料 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、獣医学的医薬品用フルララネル有効医薬品成分のグローバル市場規模と予測を記載しています。・獣医学的医薬品用フルララネル有効医薬品成分のグローバル市場：売上、2017年-2022年、2023年-2028年 ・獣医学的医薬品用フルララネル有効医薬品成分のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 獣医学的医薬品用フルララネル有効医薬品成分のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「純度98%以上」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 獣医学的医薬品用フルララネル有効医薬品成分のグローバル主要企業は、Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnologyなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、獣医学的医薬品用フルララネル有効医薬品成分のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：タイプ別、2017年-2022年、2023年-2028年 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：タイプ別市場シェア、2021年 ・純度98%以上、純度98%以下 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：用途別、2017年-2022年、2023年-2028年 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：用途別市場シェア、2021年 ・内服薬、外用薬 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：地域・国別、2017年-2022年、2023年-2028年 世界の獣医学的医薬品用フルララネル有効医薬品成分市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における獣医学的医薬品用フルララネル有効医薬品成分のグローバル売上、2017年-2022年 ・主要企業における獣医学的医薬品用フルララネル有効医薬品成分のグローバル売上シェア、2021年 ・主要企業における獣医学的医薬品用フルララネル有効医薬品成分のグローバル販売量、2017年-2022年 ・主要企業における獣医学的医薬品用フルララネル有効医薬品成分のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology ************************************************************* ・調査・分析レポートの概要 獣医学的医薬品用フルララネル有効医薬品成分市場の定義 市場セグメント 世界の獣医学的医薬品用フルララネル有効医薬品成分市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の獣医学的医薬品用フルララネル有効医薬品成分市場規模 世界の獣医学的医薬品用フルララネル有効医薬品成分市場規模：2021年 VS 2028年 世界の獣医学的医薬品用フルララネル有効医薬品成分市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの獣医学的医薬品用フルララネル有効医薬品成分の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の獣医学的医薬品用フルララネル有効医薬品成分製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：純度98%以上、純度98%以下 獣医学的医薬品用フルララネル有効医薬品成分のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：内服薬、外用薬 獣医学的医薬品用フルララネル有効医薬品成分の用途別グローバル売上・予測 ・地域別市場分析 地域別獣医学的医薬品用フルララネル有効医薬品成分市場規模 2021年と2028年 地域別獣医学的医薬品用フルララネル有効医薬品成分売上・予測 北米市場 - アメリカの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - カナダの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - メキシコの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 ヨーロッパ市場 - ドイツの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - フランスの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - イギリスの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - イタリアの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - ロシアの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 アジア市場 - 中国の獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - 日本の獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - 韓国の獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - 東南アジアの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - インドの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 南米市場 - ブラジルの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - アルゼンチンの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 中東・アフリカ市場 - トルコの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - イスラエルの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - サウジアラビアの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 - UAEの獣医学的医薬品用フルララネル有効医薬品成分市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology ... |
This report contains market size and forecasts of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in global, including the following market information:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient companies in 2021 (%)
The global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient include Nissan Chemical, HIKAL Ltd., HuBei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu Group, Zhejiang Gihi Chemicals, Hunan Huateng Pharmaceutical and Taizhou Crene Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2021 (%)
Purity ≥98%
Purity <98%
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2021 (%)
Oral Drug
External Drug
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues share in global market, 2021 (%)
Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nissan Chemical
HIKAL Ltd.
HuBei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu Group
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
1 Introduction to Research & Analysis Reports
1.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Overall Market Size
2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size: 2021 VS 2028
2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales: 2017-2028
3 Company Landscape
3.1 Top Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue by Companies
3.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales by Companies
3.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size Markets, 2021 & 2028
4.1.2 Purity ≥98%
4.1.3 Purity <98%
4.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts
4.2.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2022
4.2.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2023-2028
4.2.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2017-2028
4.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts
4.3.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2022
4.3.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2023-2028
4.3.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2017-2028
4.4 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2021 & 2028
5.1.2 Oral Drug
5.1.3 External Drug
5.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts
5.2.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2022
5.2.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2023-2028
5.2.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2017-2028
5.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts
5.3.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2022
5.3.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2023-2028
5.3.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2017-2028
5.4 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2021 & 2028
6.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts
6.2.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2022
6.2.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2023-2028
6.2.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2017-2028
6.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts
6.3.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2022
6.3.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2023-2028
6.3.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2028
6.4.2 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2028
6.4.3 US Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.4.4 Canada Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.4.5 Mexico Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2028
6.5.2 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2028
6.5.3 Germany Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.4 France Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.5 U.K. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.6 Italy Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.7 Russia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.8 Nordic Countries Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.5.9 Benelux Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2028
6.6.2 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2028
6.6.3 China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.6.4 Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.6.5 South Korea Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.6.6 Southeast Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.6.7 India Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2028
6.7.2 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2028
6.7.3 Brazil Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.7.4 Argentina Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2017-2028
6.8.3 Turkey Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.8.4 Israel Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.8.5 Saudi Arabia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
6.8.6 UAE Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Nissan Chemical
7.1.1 Nissan Chemical Corporate Summary
7.1.2 Nissan Chemical Business Overview
7.1.3 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.1.4 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.1.5 Nissan Chemical Key News
7.2 HIKAL Ltd.
7.2.1 HIKAL Ltd. Corporate Summary
7.2.2 HIKAL Ltd. Business Overview
7.2.3 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.2.4 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.2.5 HIKAL Ltd. Key News
7.3 HuBei Masteam Bio-tech
7.3.1 HuBei Masteam Bio-tech Corporate Summary
7.3.2 HuBei Masteam Bio-tech Business Overview
7.3.3 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.3.4 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.3.5 HuBei Masteam Bio-tech Key News
7.4 Jiangsu Rivocean
7.4.1 Jiangsu Rivocean Corporate Summary
7.4.2 Jiangsu Rivocean Business Overview
7.4.3 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.4.4 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.4.5 Jiangsu Rivocean Key News
7.5 Shaanxi Dideu Group
7.5.1 Shaanxi Dideu Group Corporate Summary
7.5.2 Shaanxi Dideu Group Business Overview
7.5.3 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.5.4 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.5.5 Shaanxi Dideu Group Key News
7.6 Zhejiang Gihi Chemicals
7.6.1 Zhejiang Gihi Chemicals Corporate Summary
7.6.2 Zhejiang Gihi Chemicals Business Overview
7.6.3 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.6.4 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.6.5 Zhejiang Gihi Chemicals Key News
7.7 Hunan Huateng Pharmaceutical
7.7.1 Hunan Huateng Pharmaceutical Corporate Summary
7.7.2 Hunan Huateng Pharmaceutical Business Overview
7.7.3 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.7.4 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.7.5 Hunan Huateng Pharmaceutical Key News
7.8 Taizhou Crene Biotechnology
7.8.1 Taizhou Crene Biotechnology Corporate Summary
7.8.2 Taizhou Crene Biotechnology Business Overview
7.8.3 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings
7.8.4 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2017-2022)
7.8.5 Taizhou Crene Biotechnology Key News
8 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, Analysis
8.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, 2017-2028
8.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Supply Chain Analysis
10.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Value Chain
10.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Upstream Market
10.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer